HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery (NADD)
Welcome to NADD, where our team of experts combines cutting-edge technology with our deep understanding of nucleic acids to discover new drugs that will improve the lives of our customers.
Innovating Nucleic Acid Therapeutics
At the HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery (NADD), we specialize in utilizing cutting-edge information technology to accelerate the discovery and development of nucleic acid-based drugs. Our location in Hong Kong allows us to collaborate with top researchers and pharmaceutical companies in the region to drive innovation in this field.
"Cutting-edge Nucleic Acid Solutions"
Our joint centre specializes in utilizing advanced technology and techniques for the discovery and development of nucleic acid-based drugs. Our services include computer-aided drug design, high-throughput screening, and optimization of lead compounds. We are located in Hong Kong, providing cutting-edge solutions for the advancement of nucleic acid drug discovery.
- Nucleic Acid Screening
- Drug Design Assistance
- Bioinformatics Analysis
Innovative Nucleic Acid Therapies
The HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery (NADD) is a leading research center in Hong Kong, specializing in the development of innovative nucleic acid-based drugs. Our team of experts utilizes advanced information technology to accelerate the discovery and optimization of these drugs, with the goal of improving treatment options for various diseases. Through collaboration and cutting-edge research, we strive to make a positive impact on the healthcare industry.